
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Gross Margin
Shanghai HeartCare Medical Technology Corp Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
CN |
![]() |
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
|
1.1B HKD |
65%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
223.6B USD |
56%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
181.8B USD |
67%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
150.3B USD |
69%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
139.3B USD |
64%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
107.2B USD |
66%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.2B EUR |
38%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
59.2B USD |
45%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.3B USD |
79%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
260.4B CNY |
64%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35B USD |
61%
|
Shanghai HeartCare Medical Technology Corp Ltd
Glance View
Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.

See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Shanghai HeartCare Medical Technology Corp Ltd's most recent financial statements, the company has Gross Margin of 65.4%.